肝脏和胰腺体积及脂肪含量对糖尿病风险的影响:孟德尔随机化研究
该研究利用英国生物银行参与者(n=32,859)的MRI扫描获取与肝脏和胰腺体积及脂肪含量相关的遗传变异,并从最大规模的全基因组关联研究中获取1型糖尿病(9,358例)和2型糖尿病(55,005例)的汇总数据,采用逆方差加权孟德尔随机化分析。结果显示,孟德尔随机化分析仅提供证据支持肝脏脂肪和胰腺体积在2型糖尿病风险中的因果作用(每1个标准差:肝脏脂肪比值比1.27 [1.08, 1.49],风险增加27%;胰腺体积比值比0.76 [0.62, 0.94],风险降低24%),与1型糖尿病无因果关联。
要点
- 观察性分析中,肝脏脂肪和体积与2型糖尿病相关(每1个标准差比值比分别为2.16和2.11)。
- 孟德尔随机化分析显示肝脏脂肪(比值比1.27)和胰腺体积(比值比0.76)对2型糖尿病有因果证据。
- 孟德尔随机化分析未发现与1型糖尿病的因果关联。
核心结论
- 研究结果有助于理解肝脏和胰腺异位脂肪及器官体积在1型和2型糖尿病病理生理学中的因果作用。
研究设计与样本
- 孟德尔随机化研究,利用英国生物银行参与者(n=32,859)MRI扫描获得的与暴露(肝脏和胰腺体积及脂肪含量)相关的遗传变异(P < 5 × 10-8)。
- 从最大规模的全基因组关联研究获取1型糖尿病(9,358例)和2型糖尿病(55,005例)风险的汇总数据。
- 主要分析采用逆方差加权孟德尔随机化,并进行多种敏感性分析以评估多效性并排除具有潜在多效性效应的变异。
主要发现
- 观察性分析中,肝脏脂肪和体积与2型糖尿病相关(每1个标准差比值比分别为2.16 [2.02, 2.31]和2.11 [1.96, 2.27])。
- 观察性分析中,胰腺脂肪与2型糖尿病相关(比值比1.42 [1.34, 1.51]),但与1型糖尿病无关;胰腺体积与1型糖尿病(比值比0.42 [0.36, 0.48])和2型糖尿病(比值比0.73 [0.68, 0.78])呈负相关。
- 孟德尔随机化分析仅提供证据支持肝脏脂肪和胰腺体积在2型糖尿病风险中的因果作用(每1个标准差比值比分别为1.27 [1.08, 1.49],风险增加27%;0.76 [0.62, 0.94],风险降低24%),与1型糖尿病无因果关联。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Fat content and volume of liver and pancreas are associated with risk of diabetes in observational studies; whether these associations are causal is unknown. We conducted a Mendelian randomization (MR) study to examine causality of such associations. RESEARCH DESIGN AND METHODS: We used genetic variants associated (P < 5 × 10-8) with the exposures (liver and pancreas volume and fat content) using MRI scans of UK Biobank participants (n = 32,859). We obtained summary-level data for risk of type 1 (9,358 cases) and type 2 (55,005 cases) diabetes from the largest available genome-wide association studies. We performed inverse-variance weighted MR as main analysis and several sensitivity analyses to assess pleiotropy and to exclude variants with potential pleiotropic effects. RESULTS: Observationally, liver fat and volume were associated with type 2 diabetes (odds ratio per 1 SD higher exposure 2.16 [2.02, 2.31] and 2.11 [1.96, 2.27], respectively). Pancreatic fat was associated with type 2 diabetes (1.42 [1.34, 1.51]) but not type 1 diabetes, and pancreas volume was negatively associated with type 1 diabetes (0.42 [0.36, 0.48]) and type 2 diabetes (0.73 [0.68, 0.78]). MR analysis provided evidence only for a causal role of liver fat and pancreas volume in risk of type 2 diabetes (1.27 [1.08, 1.49] or 27% increased risk and 0.76 [0.62, 0.94] or 24% decreased risk per 1SD, respectively) and no causal associations with type 1 diabetes. CONCLUSIONS: Our findings assist in understanding the causal role of ectopic fat in the liver and pancreas and of organ volume in the pathophysiology of type 1 and type 2 diabetes.
引用
- Martin S, Sorokin EP, Thomas EL, et al. Estimating the Effect of Liver and Pancreas Volume and Fat Content on Risk of Diabetes: A Mendelian Randomization Study. Diabetes Care. 2022. PMID: 34983059. doi:10.2337/dc21-1262
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。